Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
Chevron
CVX
|
+$331M |
| 2 |
Walmart
WMT
|
+$229M |
| 3 |
Linde
LIN
|
+$187M |
| 4 |
PayPal
PYPL
|
+$145M |
| 5 |
Union Pacific
UNP
|
+$126M |
Top Sells
| 1 |
NVIDIA
NVDA
|
+$903M |
| 2 |
Uber
UBER
|
+$565M |
| 3 |
Exxon Mobil
XOM
|
+$450M |
| 4 |
Novo Nordisk
NVO
|
+$393M |
| 5 |
Apple
AAPL
|
+$317M |
Sector Composition
| 1 | Technology | 18.82% |
| 2 | Healthcare | 17.05% |
| 3 | Consumer Discretionary | 13.22% |
| 4 | Financials | 8.79% |
| 5 | Consumer Staples | 7.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3201
AYTU BioPharma
AYTU
$20.6M
| $217K | ﹤0.01% |
71,323
+2,400
| +3% | +$7.3K |
|
|
RGLS
3202
DELISTED
Regulus Therapeutics
RGLS
| $217K | ﹤0.01% |
75,500
+20,900
| +38% | +$60.1K |
|
3203
Lindblad Expeditions
LIND
$758M
| $216K | ﹤0.01% |
+23,200
| New | +$216K |
|
3204
Surrozen
SRZN
$101M
| $216K | ﹤0.01% |
13,726
+3,400
| +33% | +$53.5K |
|
3205
Blue Ridge Bankshares
BRBS
$380M
| $215K | ﹤0.01% |
80,051
+38,551
| +93% | +$104K |
|
3206
Anixa Biosciences
ANIX
$95M
| $215K | ﹤0.01% |
+68,800
| New | +$215K |
|
3207
Armata Pharmaceuticals
ARMP
$107M
| $215K | ﹤0.01% |
51,396
-2,200
| -4% | -$9.2K |
|
3208
iShares Global REIT ETF
REET
$3.92B
| $213K | ﹤0.01% |
+9,000
| New | +$213K |
|
|
SPRB
3209
DELISTED
Spruce Biosciences, Inc. Common Stock
SPRB
| $213K | ﹤0.01% |
271,000
+85,900
| +46% | +$67.5K |
|
3210
NB Bancorp
NBBK
$738M
| $212K | ﹤0.01% |
+15,500
| New | +$212K |
|
3211
Synlogic
SYBX
$17.9M
| $212K | ﹤0.01% |
118,435
+63,805
| +117% | +$114K |
|
3212
Senseonics Holdings
SENS
$370M
| $211K | ﹤0.01% |
396,600
-515,500
| -57% | -$274K |
|
3213
Outlook Therapeutics
OTLK
$50.6M
| $210K | ﹤0.01% |
17,600
+12,329
| +234% | +$147K |
|
|
WDH
3214
Waterdrop
WDH
$673M
| $210K | ﹤0.01% |
162,736
+136,536
| +521% | +$176K |
|
3215
authID Inc
AUID
$45.3M
| $209K | ﹤0.01% |
27,428
+7,800
| +40% | +$59.4K |
|
3216
Richmond Mutual Bancorp
RMBI
$141M
| $208K | ﹤0.01% |
18,742
+1,300
| +7% | +$14.4K |
|
3217
SB Financial Group
SBFG
$138M
| $208K | ﹤0.01% |
15,125
-118
| -0.8% | -$1.62K |
|
3218
Offerpad Solutions
OPAD
$143M
| $207K | ﹤0.01% |
25,553
-8,200
| -24% | -$66.4K |
|
|
VIRX
3219
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
| $207K | ﹤0.01% |
202,499
+23,600
| +13% | +$24.1K |
|
3220
Katapult Holdings
KPLT
$89.2M
| $206K | ﹤0.01% |
17,700
+2,796
| +19% | +$32.5K |
|
3221
MIND Technology
MIND
$66.5M
| $205K | ﹤0.01% |
44,940
-900
| -2% | -$4.11K |
|
3222
Schwab International Small-Cap Equity ETF
SCHC
$4.91B
| $204K | ﹤0.01% |
5,700
-4,023
| -41% | -$144K |
|
|
VIGL
3223
DELISTED
Vigil Neuroscience
VIGL
| $204K | ﹤0.01% |
+59,964
| New | +$204K |
|
3224
Key Tronic
KTCC
$36.7M
| $203K | ﹤0.01% |
43,600
+6,300
| +17% | +$29.3K |
|
|
DOMA
3225
DELISTED
Doma Holdings, Inc.
DOMA
| $203K | ﹤0.01% |
44,807
+1,400
| +3% | +$6.34K |
|